Fidelity Investments’s Prelude Therapeutics PRLD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.04K | Sell |
11,167
-9,071
| -45% | -$7.34K | ﹤0.01% | 4557 |
|
|
2025
Q1 | $15.5K | Buy |
20,238
+11,736
| +138% | +$9.01K | ﹤0.01% | 4325 |
|
|
2024
Q4 | $10.8K | Buy |
8,502
+884
| +12% | +$1.13K | ﹤0.01% | 4440 |
|
|
2024
Q3 | $15.8K | Sell |
7,618
-1,957
| -20% | -$4.05K | ﹤0.01% | 4277 |
|
|
2024
Q2 | $36.5K | Sell |
9,575
-1,975
| -17% | -$7.53K | ﹤0.01% | 3779 |
|
|
2024
Q1 | $54.7K | Sell |
11,550
-253,137
| -96% | -$1.2M | ﹤0.01% | 3537 |
|
|
2023
Q4 | $1.13M | Sell |
264,687
-4,866,746
| -95% | -$20.8M | ﹤0.01% | 2439 |
|
|
2023
Q3 | $15.9M | Sell |
5,131,433
-808,787
| -14% | -$2.5M | ﹤0.01% | 1672 |
|
|
2023
Q2 | $26.7M | Buy |
5,940,220
+1,393,542
| +31% | +$6.27M | ﹤0.01% | 1523 |
|
|
2023
Q1 | $25.9M | Sell |
4,546,678
-42,914
| -0.9% | -$245K | ﹤0.01% | 1512 |
|
|
2022
Q4 | $27.7M | Sell |
4,589,592
-48,955
| -1% | -$296K | ﹤0.01% | 1489 |
|
|
2022
Q3 | $30.7M | Buy |
4,638,547
+335,578
| +8% | +$2.22M | ﹤0.01% | 1446 |
|
|
2022
Q2 | $22.5M | Sell |
4,302,969
-1,068,938
| -20% | -$5.58M | ﹤0.01% | 1605 |
|
|
2022
Q1 | $37.1M | Sell |
5,371,907
-567,026
| -10% | -$3.91M | ﹤0.01% | 1518 |
|
|
2021
Q4 | $73.9M | Sell |
5,938,933
-1,116,733
| -16% | -$13.9M | 0.01% | 1253 |
|
|
2021
Q3 | $220M | Buy |
7,055,666
+503,167
| +8% | +$15.7M | 0.02% | 763 |
|
|
2021
Q2 | $188M | Buy |
6,552,499
+300,392
| +5% | +$8.6M | 0.01% | 855 |
|
|
2021
Q1 | $271M | Buy |
6,252,107
+2,042,144
| +49% | +$88.5M | 0.02% | 650 |
|
|
2020
Q4 | $296M | Buy |
4,209,963
+1,081,579
| +35% | +$76.1M | 0.03% | 584 |
|
|
2020
Q3 | $90.1M | Buy |
+3,128,384
| New | +$90.1M | 0.01% | 955 |
|